Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dextropropoxyphene measurement |
Component |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dextropropoxyphene (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Poisoning by co-proxamol |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Deliberate overdose of co-proxamol |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen and dextropropoxyphene poisoning |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental acetaminophen and dextropropoxyphene poisoning |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional acetaminophen and dextropropoxyphene poisoning |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen and dextropropoxyphene poisoning of undetermined intent |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental poisoning by co-proxamol |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional poisoning by co-proxamol |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by co-proxamol of undetermined intent |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene poisoning (disorder) |
Causative agent (attribute) |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental dextropropoxyphene poisoning |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional dextropropoxyphene poisoning |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par le dextropropoxyphène d'intention indéterminée |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dextropropoxyphene adverse reaction |
Causative agent (attribute) |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to propoxyphene |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol and dextropropoxyphene overdose |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental paracetamol and dextropropoxyphene overdose |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Intentional paracetamol and dextropropoxyphene overdose |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol and dextropropoxyphene overdose of undetermined intent |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Overdose of co-proxamol |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental overdose by co-proxamol |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Overdose of co-proxamol of undetermined intent |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene overdose |
Causative agent (attribute) |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental dextropropoxyphene overdose |
Causative agent (attribute) |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional dextropropoxyphene overdose |
Causative agent (attribute) |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de dextropropoxyphène d'intention indéterminée |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to acetaminophen and dextropropoxyphene |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dextropropoxyphene hydrochloride 65 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dextropropoxyphene napsylate 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Urine dextropropoxyphene level (procedure) |
Component |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Propoxyphene measurement |
Component |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing aspirin and caffeine and propoxyphene hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing paracetamol and propoxyphene napsylate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing propoxyphene hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing propoxyphene napsylate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene napsylate 100 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental acetaminophen and dextropropoxyphene poisoning |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Intentional acetaminophen and dextropropoxyphene poisoning |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental poisoning by co-proxamol |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional poisoning by co-proxamol |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental dextropropoxyphene poisoning |
Causative agent (attribute) |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional dextropropoxyphene poisoning |
Causative agent (attribute) |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Co-proxamol 32.5mg/325mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-proxamol 32.5mg/325mg/5mL s/f suspension (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dextropropoxyphene and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene hydrochloride |
Is a |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene napsylate |
Is a |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Urine propoxyphene screening test (procedure) |
Component |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Quantitative measurement of mass concentration of dextropropoxyphene in serum or plasma specimen using gas chromatography mass spectrometry technique (procedure) |
Component |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Allergy to propoxyphene |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Allergy to acetaminophen and dextropropoxyphene |
Causative agent (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Co-proxamol 32.5mg/325mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Co-proxamol 32.5mg/325mg tablet (substance) |
Has basis of strength substance (attribute) |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dextropropoxyphene hydrochloride |
Is modification of (attribute) |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene napsylate |
Is modification of (attribute) |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen+dextropropoxyphene hydrochloride 325mg/32.5mg/5mL conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-proxamol 32.5mg/325mg tablet (substance) |
Has precise active ingredient |
False |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin- and caffeine- and dextropropoxyphene-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextropropoxyphene- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dextropropoxyphene-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing aspirin and caffeine and dextropropoxyphene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and caffeine and dextropropoxyphene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextropropoxyphene only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dextropropoxyphene and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only dextropropoxyphene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aspirin and caffeine and dextropropoxyphene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextropropoxyphene and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to propoxyphene |
Causative agent (attribute) |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Quantitative measurement of mass concentration of dextropropoxyphene in serum or plasma specimen using gas chromatography mass spectrometry technique (procedure) |
Component |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Urine dextropropoxyphene level (procedure) |
Component |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Urine propoxyphene screening test (procedure) |
Component |
True |
Dextropropoxyphene |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |